- Sonus Pharmaceuticals terminates Synt:em buy
- Immuno-Designed Molecules files for, withdraws €98.8mm IPO
- Synt:em raises $20mm in private placement
- Novuspharma raises $173.45mm with IPO
- Cell Therapeutics acquires Novuspharma
- Versicor merges with Biosearch Italia in $234mm stock swap
- Serono to buy Genset
- CareX raises €25mm in Series B round
- Faust gets €16mm in second round private placement
- Sanofi-Aventis spins off Novexel
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.